Teleflex Incorporated (NYSE:TFX) Short Interest Update

Teleflex Incorporated (NYSE:TFX) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 2,420,000 shares, a growth of 116.1% from the February 28th total of 1,120,000 shares. Currently, 5.2% of the company’s shares are short sold. Based on an average daily trading volume, of 998,200 shares, the short-interest ratio is presently 2.4 days.

Teleflex Trading Down 1.2 %

Shares of NYSE:TFX traded down $1.61 during mid-day trading on Friday, reaching $137.76. 776,408 shares of the company were exchanged, compared to its average volume of 579,236. Teleflex has a 1 year low of $128.55 and a 1 year high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The firm’s 50-day simple moving average is $159.20 and its 200 day simple moving average is $190.36. The firm has a market cap of $6.39 billion, a price-to-earnings ratio of 27.39, a P/E/G ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Equities research analysts forecast that Teleflex will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 annualized dividend and a dividend yield of 0.99%. Teleflex’s dividend payout ratio is presently 95.77%.

Analysts Set New Price Targets

A number of brokerages have issued reports on TFX. Piper Sandler reaffirmed a “neutral” rating and issued a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research report on Friday, February 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Truist Financial dropped their price target on shares of Teleflex from $200.00 to $149.00 and set a “hold” rating for the company in a research note on Monday, March 3rd. Finally, StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $182.63.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TFX. T. Rowe Price Investment Management Inc. lifted its holdings in Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock worth $1,098,693,000 after buying an additional 261,279 shares in the last quarter. Janus Henderson Group PLC increased its position in shares of Teleflex by 2.8% during the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares during the period. State Street Corp raised its stake in shares of Teleflex by 1.0% in the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Teleflex by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after purchasing an additional 8,307 shares during the period. Finally, Cooke & Bieler LP grew its stake in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock worth $191,962,000 after purchasing an additional 195,150 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.